Bladder cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients with complete baseline clinical data and postoperative adjuvant treatment information (e.g., chemotherapy, immunotherapy, etc.); 2.Pathologically confirmed diagnosis of malignant bladder tumor, including muscle-invasive bladder cancer (MIBC) and high-risk non-muscle-invasive bladder cancer (HR-NMIBC), confirmed preoperatively or postoperatively; 3.Have undergone radical cystectomy and are either planned to receive or currently receiving adjuvant therapy; 4.Age >=18 years, no restriction on sex; 5.No history of active malignant tumors at other anatomical sites.
Exclusion criteria
Exclusion criteria: 1.Patients without bladder cancer or those who have not undergone radical cystectomy; 2.Patients who have not received or have declined adjuvant therapy; 3.Patients with a history of other malignant tumors that are currently active; 4.Patients with severe cardiopulmonary dysfunction, liver or renal failure, or other major comorbidities that render them unfit for adjuvant therapy; 5.Patients who are unable to comply with follow-up or complete required clinical assessments.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recurrence-Free Survival, RFS; | — |
Countries
China
Contacts
Zhejiang Provincial People's Hospital